Finally, we found that CCH disrupts the sphingolipid metabolism by affecting the mRNA expression of SMPD1 and SMS2, leading to the accumulation of sphingomyelin in the prefrontal cortex. The gene discussed is SGMS2; the disease is columnar cell hyperplasia of the breast.